Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Inogen, Inc. (INGN) Institutional Ownership & Insider Trading

129 institutions reported holding Inogen, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 2 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

INGNInogen, Inc.Follow INGN — free
Medical Devices · Healthcare
—
Price chart with a free account
Market cap
188.4M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
5 Nov, in 12 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

129 institutions held 72.8% of the shares. Across filers that reported both quarters, shares held changed +1.8%.

Increased+60New+18Decreased-26Closed-9

Largest moves, shares (millions)

AQR Capital Management+0.5MReadystate Asset Management+0.3MMackenzie Financial+0.2MPoint72 Asset Management-0.5MQube Research & Technologies-0.2MPerkins Capital Management-0.2M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
-2.3Sep 24-1.0Dec 24-1.4Mar 25+0.9Jun 25+0.1Sep 25+0.6Dec 25+0.2Mar 26+0.4Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 2612919+1.8%6018269
Mar 2612619+1.4%42154122
Dec 2513119+3.2%31145311
Sep 2512619+0.7%39174213
Jun 2512420+4.9%44134013
Mar 2512619-6.8%48143420
Dec 2413420-4.7%47172817
Sep 2413120-11.3%35213516

Inogen, Inc. — questions

Who owns Inogen, Inc. stock?
129 institutions reported Inogen, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (6.6%), ACADIAN ASSET MANAGEMENT LLC (4.1%), ARMISTICE CAPITAL, LLC (4.1%).
Are Inogen, Inc. insiders buying or selling?
2 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Inogen, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.